BACKGROUND: Bipolar disorder (BD) is associated with inhibitory deficits characterized by a reduced ability to control inappropriate actions or thoughts. While aspects of inhibition such as exaggerated novelty-seeking and perseveration are quantified in rodent exploration of novel environments, similar models are rarely applied in humans. The human Behavioral Pattern Monitor (hBPM), a cross-species exploratory paradigm, has identified a pattern of impaired inhibitory function in manic BD participants, but this phenotype has not been examined across different BD phases. The objective of this study was to determine if euthymic BD individuals demonstrate inhibitory deficits in the hBPM, supporting disinhibition as an endophenotype for the disorder. METHODS: 25 euthymic BD outpatients and 51 healthy comparison subjects were assessed in the hBPM, where activity was recorded by a concealed videocamera and an ambulatory monitoring sensor. RESULTS: Euthymic BD individuals, similar to manic subjects, demonstrated increased motor activity, greater interaction with novel objects, and more frequent perseverative behavior relative to comparison participants. The quantity of locomotion was also reduced in BD individuals treated with mood stabilizers compared to other patients. LIMITATIONS: Low sample size for treatment subgroups limits the evaluation of specific medication regimens. CONCLUSIONS: Our results suggest that BD is distinguished by both trait- and state-dependent inhibitory deficits optimally assessed with sophisticated multivariate measures. These data support the use of the hBPM as a tool to elucidate the effects of BD across various illness states, facilitate the development of BD animal models, and advance our understanding of the neurobiology underlying the disorder.
BACKGROUND:Bipolar disorder (BD) is associated with inhibitory deficits characterized by a reduced ability to control inappropriate actions or thoughts. While aspects of inhibition such as exaggerated novelty-seeking and perseveration are quantified in rodent exploration of novel environments, similar models are rarely applied in humans. The human Behavioral Pattern Monitor (hBPM), a cross-species exploratory paradigm, has identified a pattern of impaired inhibitory function in manic BDparticipants, but this phenotype has not been examined across different BD phases. The objective of this study was to determine if euthymic BD individuals demonstrate inhibitory deficits in the hBPM, supporting disinhibition as an endophenotype for the disorder. METHODS: 25 euthymic BD outpatients and 51 healthy comparison subjects were assessed in the hBPM, where activity was recorded by a concealed videocamera and an ambulatory monitoring sensor. RESULTS: Euthymic BD individuals, similar to manic subjects, demonstrated increased motor activity, greater interaction with novel objects, and more frequent perseverative behavior relative to comparison participants. The quantity of locomotion was also reduced in BD individuals treated with mood stabilizers compared to other patients. LIMITATIONS: Low sample size for treatment subgroups limits the evaluation of specific medication regimens. CONCLUSIONS: Our results suggest that BD is distinguished by both trait- and state-dependent inhibitory deficits optimally assessed with sophisticated multivariate measures. These data support the use of the hBPM as a tool to elucidate the effects of BD across various illness states, facilitate the development of BD animal models, and advance our understanding of the neurobiology underlying the disorder.
Authors: Dara G Ghahremani; Buyean Lee; Chelsea L Robertson; Golnaz Tabibnia; Andrew T Morgan; Natalie De Shetler; Amira K Brown; John R Monterosso; Adam R Aron; Mark A Mandelkern; Russell A Poldrack; Edythe D London Journal: J Neurosci Date: 2012-05-23 Impact factor: 6.167
Authors: Lauren E Lombardo; Carrie E Bearden; Jennifer Barrett; Margaret S Brumbaugh; Brian Pittman; Sophia Frangou; David C Glahn Journal: Bipolar Disord Date: 2012-07-16 Impact factor: 6.744
Authors: I J Torres; C M DeFreitas; V G DeFreitas; D J Bond; M Kunz; W G Honer; R W Lam; L N Yatham Journal: Psychol Med Date: 2011-05 Impact factor: 7.723
Authors: Brook L Henry; Arpi Minassian; Jared W Young; Martin P Paulus; Mark A Geyer; William Perry Journal: Neurosci Biobehav Rev Date: 2010-04-14 Impact factor: 8.989
Authors: Adriane R Rosa; María Reinares; Erin E Michalak; C Mar Bonnin; Brisa Sole; Carolina Franco; Mercè Comes; Carla Torrent; Flávio Kapczinski; Eduard Vieta Journal: Value Health Date: 2010-12 Impact factor: 5.725
Authors: Dina R Hirshfeld-Becker; Joseph Biederman; Sara Calltharp; Eliza D Rosenbaum; Stephen V Faraone; Jerrold F Rosenbaum Journal: Biol Psychiatry Date: 2003-06-01 Impact factor: 13.382
Authors: Anabel Martínez-Arán; Eduard Vieta; María Reinares; Francesc Colom; Carla Torrent; Jose Sánchez-Moreno; Antonio Benabarre; José Manuel Goikolea; Mercè Comes; Manel Salamero Journal: Am J Psychiatry Date: 2004-02 Impact factor: 18.112
Authors: Arpi Minassian; Brook L Henry; Mark A Geyer; Martin P Paulus; Jared W Young; William Perry Journal: J Affect Disord Date: 2010-01 Impact factor: 4.839
Authors: Jordy van Enkhuizen; Mark A Geyer; Arpi Minassian; William Perry; Brook L Henry; Jared W Young Journal: Neurosci Biobehav Rev Date: 2015-08-19 Impact factor: 8.989
Authors: Jordy van Enkhuizen; Morgane Milienne-Petiot; Mark A Geyer; Jared W Young Journal: Psychopharmacology (Berl) Date: 2015-07-05 Impact factor: 4.530
Authors: Jordy van Enkhuizen; Mark A Geyer; Adam L Halberstadt; Xiaoxi Zhuang; Jared W Young Journal: J Affect Disord Date: 2013-11-16 Impact factor: 4.839
Authors: Jordy van Enkhuizen; Brook L Henry; Arpi Minassian; William Perry; Morgane Milienne-Petiot; Kerin K Higa; Mark A Geyer; Jared W Young Journal: Neuropsychopharmacology Date: 2014-07-09 Impact factor: 7.853
Authors: Arpi Minassian; Jared W Young; Zackary A Cope; Brook L Henry; Mark A Geyer; William Perry Journal: Psychopharmacology (Berl) Date: 2015-10-09 Impact factor: 4.530